Fig. 6From: Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinomaOverview of impact of 18F-FAPI PET/CT on staging and therapeutic management in HCC, therapeutic management was altered in 31 of 67 individualsBack to article page